SPOTLIGHT: Merck KGaA clears way for Bayer

Merck KGaA has agreed to sell its 21.8 percent stake in Schering to Bayer, clearing the way for Bayer's takeover. Article (WSJ sub. req.)

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.